Does a Rapid Decline in the Hematological and Biochemical Parameters Induced by Interferon and Ribavirin Combination Therapy for the Hepatitis C Virus Predict a Sustained Viral Response?

Does a Rapid Decline in the Hematological and Biochemical Parameters Induced by Interferon and Ribavirin Combination Therapy for the Hepatitis C Virus Predict a Sustained Viral Response?

BACKGROUND AND OBJECTIVES: To analyze whether rapid myelosuppression and a decrease in alanine aminotransferase (ALT) induced by standard interferon (IFN) and ribavirin (RBV) combination therapy predict a sustained viral response (SVR) in hepatitis C virus patients.

Bibliographic Details
Main Authors:	Christian Turbide, Constantine A Soulellis, Marc Deschênes, Nir Hilzenrat
Format:	Article
Language:	English
Published:	Hindawi Limited 2008-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2008/213897

Similar Items

Hematological Side Effects During Combination Therapy With Interferon and Ribavirin In Chronic Hepatitis C
by: Komal Owais
Published: (2015-06-01)

Ribavirin in acute viral hepatitis.
by: Tilve G, et al.
Published: (1991-07-01)

Characteristics of hepatitis C treatment with pegylated interferons and ribavirin
by: Ricardo Jiménez-Méndez, et al.
Published: (2010-01-01)

Histological response study of chronic viral hepatitis C patients treated with interferon alone or combined with ribavirin
by: Kleber Prado, et al.

Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients
by: I. Ollivier-Hourmand, et al.
Published: (2020-07-01)

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
by: Suzanne Tavitian, et al.
Published: (2015-08-01)

HEMATOLOGICAL AND BIOCHEMICAL MODIFICATIONS IN MALE PATIENTS WITH VIRAL HEPATITIS B
by: Elena Todirascu-Ciornea, et al.
Published: (2016-05-01)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
by: Gonçales Neiva SL, et al.
Published: (2010-07-01)

Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy
by: Curtis Cooper, et al.
Published: (2014-01-01)

Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review
by: J Shepherd, et al.
Published: (2000-12-01)

Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin
by: Jafroodi M, et al.
Published: (2011-07-01)

Standard Interferon and Ribavirin Response in Patients with Chronic Hepatitis C
by: Muhammad Murtaza Bukhari
Published: (2013-12-01)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
by: Roberto J Carvalho-Filho, et al.
Published: (2010-03-01)

Early viral kinetics on treatment with combination of pegylated interferon-α and ribavirin in chronic hepatitis C virus infection
by: Ching-Sheng Hsu, et al.
Published: (2005)

Comparison study between the treatment of Hepatitis C virus with (peg-interferon, ribavirin, silymarin) and (peg-interferon, ribavirin) in Baghdad teaching hospital.
by: Khalid A. Al-Khazraji
Published: (2017-04-01)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
by: Saleem Sana, et al.
Published: (2011-05-01)

Discrepancy between Virological and Biochemical Responses at the End of Interferon or Peginterferon plus Ribavirin Treatment for Chronic Hepatitis C Patients
by: Chun-Hao Chen, et al.
Published: (2008)

Effectiveness of alpha interferon (+ ribavirin) in the treatment of chronic viral hepatitis C genotypes 2 and 3 in a brazilian sample
by: Candice Beatriz Treter Gonçalves, et al.
Published: (2012-06-01)

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
by: Mario Espinosa, et al.
Published: (2015-05-01)

Response of Hepatitis C Patients to Alpha Interferon and Ribavirin Combination Therapy
by: Ihsanullah Mahsud, et al.
Published: (2004-06-01)

Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
by: T Kanda, et al.
Published: (2011-03-01)

Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01)

Ribavirin plus interferon alfa in the treatment of chronic hepatitis C infection
by: Wen Hwang Chen, et al.
Published: (2000)

A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients.
by: Leonid I Brodsky, et al.
Published: (2007-07-01)

Relapse of Vogt-Koyanagi-Harada Disease during Interferon-α and Ribavirin Therapy in a Case of Chronic Viral Hepatitis C
by: Miho Soma, et al.
Published: (2011-01-01)

Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load
by: Kenji Ando, et al.
Published: (2009-11-01)

Association of SNPs In Interferon Receptor Genes in Chronic Hepatitis C with Response to Combined Therapy of Interferon and Ribavirin
by: Zohreh Heidari, et al.
Published: (2014-10-01)

High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C
by: David N Moskovitz, et al.
Published: (2003-01-01)

TREATMENTS OF HEPATITIS C VIRUS LIVER CIRRHOSIS WITH PEGYLAT INTERFERON-RIBAVIRIN AND INTERFERON FREE – COMPARATIVE STUDY
by: S.A. Florescu, et al.
Published: (2016-12-01)

Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients.
by: Antonio Rivero-Juárez, et al.
Published: (2012-01-01)

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
by: Aline Gonzalez Vigani, MD, PhD, et al.
Published: (2010-03-01)

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
by: Aline Gonzalez Vigani, et al.

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
by: Debora Lucia Seguro Danilovic, et al.
Published: (2011-01-01)

Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C
by: Chi-Hsuan Chiang, et al.
Published: (2014-12-01)

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
by: Byung Chul You, et al.
Published: (2012-09-01)

Combined pegylated interferon and ribavirin for the management of chronic hepatitis C in a prison setting
by: Sergio Sabbatani, et al.

Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
by: Luis Jesuíno de Oliveira Andrade, et al.

Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
by: Luis Jesuino de Oliveira Andrade, et al.

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Edmundo P.A. Lopes, et al.

Therapy with interferon-a plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Lopes Edmundo P.A., et al.
Published: (2003-01-01)